NADPH oxidase-dependent oxidative stress in the failing heart: From pathogenic roles to therapeutic approach

Free Radical Biology and Medicine

Volumn 52, Issue 2, 2012, Pages 291-297

  Octavia, Yanti ^a   Brunner La Rocca, Hans Peter ^a   Moens, An L ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Free radicals; Heart failure; Myocardial dysfunction; NADPH oxidases; Reactive oxygen species; Ventricular remodeling

Indexed keywords

CASPASE 3; CYTOCHROME P450; DOXORUBICIN; GLUTATHIONE PEROXIDASE 1; PROTEIN P22; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2;

CARDIOTOXICITY; DIABETIC CARDIOMYOPATHY; HEART ATRIUM ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HUMAN; MYOCARDITIS; NONHUMAN; OXIDATIVE STRESS; PATHOLOGY; PERICARDITIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; DIABETIC CARDIOMYOPATHIES; DOXORUBICIN; ENZYME INHIBITORS; HEART FAILURE; HUMANS; HYPERTENSION; MYOCARDITIS; NADPH OXIDASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; VENTRICULAR REMODELING;

EID: 84855440127     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2011.10.482     Document Type: Review

References (100)

1. V.L. Roger, S.A. Weston, M.M. Redfield, J.P. Hellermann-Homan, J. Killian, B.P. Yawn, and S.J. Jacobsen Trends in heart failure incidence and survival in a community-based population JAMA 292 2004 344 350 (Pubitemid 38944258)
2. D. Levy, S. Kenchaiah, M.G. Larson, E.J. Benjamin, M.J. Kupka, K.K. Ho, J.M. Murabito, and R.S. Vasan Long-term trends in the incidence of and survival with heart failure N. Engl. J. Med. 347 2002 1397 1402 (Pubitemid 35239711)
3. D.F. Dai, S.C. Johnson, J.J. Villarin, M.T. Chin, M. Nieves-Cintron, T. Chen, D.J. Marcinek, G.W. Dorn II, Y.J. Kang, T.A. Prolla, L.F. Santana, and P.S. Rabinovitch Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Gαq overexpression-induced heart failure Circ. Res. 108 2011 837 846
4. K.M. Minhas, R.M. Saraiva, K.H. Schuleri, S. Lehrke, M. Zheng, A.P. Saliaris, C.E. Berry, L.A. Barouch, K.M. Vandegaer, D. Li, and J.M. Hare Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy Circ. Res. 98 2006 271 279
5. A.L. Moens, E. Takimoto, C.G. Tocchetti, K. Chakir, D. Bedja, G. Cormaci, E.A. Ketner, M. Majmudar, K. Gabrielson, M.K. Halushka, J.B. Mitchell, S. Biswal, K.M. Channon, M.S. Wolin, N.J. Alp, N. Paolocci, H.C. Champion, and D.A. Kass Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy Circulation 117 2008 2626 2636
6. J. Kuroda, T. Ago, S. Matsushima, P. Zhai, M.D. Schneider, and J. Sadoshima NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart Proc. Natl. Acad. Sci. U. S. A. 107 2010 15565 15570
7. C.E. Murdoch, M. Zhang, A.C. Cave, and A.M. Shah NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure Cardiovasc. Res. 71 2006 208 215
8. J.M. Li, N.P. Gall, D.J. Grieve, M. Chen, and A.M. Shah Activation of NADPH oxidase during progression of cardiac hypertrophy to failure Hypertension 40 2002 477 484
9. D.J. Grieve, and A.M. Shah Oxidative stress in heart failure: more than just damage Eur. Heart J. 24 2003 2161 2163 (Pubitemid 37522667)
10. E. Takimoto, H.C. Champion, M. Li, S. Ren, E.R. Rodriguez, B. Tavazzi, G. Lazzarino, N. Paolocci, K.L. Gabrielson, Y. Wang, and D.A. Kass Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load J. Clin. Invest. 115 2005 1221 1231 (Pubitemid 40629040)
11. F.J. Giordano Oxygen, oxidative stress, hypoxia, and heart failure J. Clin. Invest. 115 2005 500 508 (Pubitemid 40322219)
12. D.A. Siwik, P.J. Pagano, and W.S. Colucci Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts Am. J. Physiol. Cell Physiol. 280 2001 C53 C60
13. K. Grote, I. Flach, M. Luchtefeld, E. Akin, S.M. Holland, H. Drexler, and B. Schieffer Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species Circ. Res. 92 2003 e80 e86
14. M.T. Quinn, and K.A. Gauss Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases J. Leukoc. Biol. 76 2004 760 781 (Pubitemid 39313712)
15. J.D. Lambeth NOX enzymes and the biology of reactive oxygen Nat. Rev. Immunol. 4 2004 181 189 (Pubitemid 38339084)
16. N. Opitz, G.R. Drummond, S. Selemidis, S. Meurer, and H.H. Schmidt The 'A's and 'O's of NADPH oxidase regulation: a commentary on "Subcellular localization and function of alternatively spliced Noxo1 isoforms Free Radic. Biol. Med. 42 2007 175 179 (Pubitemid 44959749)
17. A.N. Lyle, and K.K. Griendling Modulation of vascular smooth muscle signaling by reactive oxygen species Physiology (Bethesda) 21 2006 269 280 (Pubitemid 44156859)
18. B. Lassegue, D. Sorescu, K. Szocs, Q. Yin, M. Akers, Y. Zhang, S.L. Grant, J.D. Lambeth, and K.K. Griendling Novel gp91(phox) homologues in vascular smooth muscle cells: Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways Circ. Res. 88 2001 888 894 (Pubitemid 32441466)
19. A.M. Briones, F. Tabet, G.E. Callera, A.C. Montezano, A. Yogi, Y. He, M.T. Quinn, M. Salaices, and R.M. Touyz Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR J. Am. Soc. Hypertens. 5 2011 137 153
20. B. Lassegue, and K.K. Griendling NADPH oxidases: functions and pathologies in the vasculature Arterioscler. Thromb. Vasc. Biol. 30 2010 653 661
21. A. Akki, M. Zhang, C. Murdoch, A. Brewer, and A.M. Shah NADPH oxidase signaling and cardiac myocyte function J. Mol. Cell. Cardiol. 47 2009 15 22
22. L.H. Opie, P.J. Commerford, B.J. Gersh, and M.A. Pfeffer Controversies in ventricular remodelling Lancet 367 2006 356 367 (Pubitemid 43151469)
23. S. Hein, E. Arnon, S. Kostin, M. Schonburg, A. Elsasser, V. Polyakova, E.P. Bauer, W.P. Klovekorn, and J. Schaper Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms Circulation 107 2003 984 991 (Pubitemid 36258721)
24. N.S. Dhalla, R.M. Temsah, and T. Netticadan Role of oxidative stress in cardiovascular diseases J. Hypertens. 18 2000 655 673 (Pubitemid 30406736)
25. A.K. Dhalla, M.F. Hill, and P.K. Singal Role of oxidative stress in transition of hypertrophy to heart failure J. Am. Coll. Cardiol. 28 1996 506 514 (Pubitemid 26274350)
26. M. Maytin, D.A. Siwik, M. Ito, L. Xiao, D.B. Sawyer, R. Liao, and W.S. Colucci Pressure overload-induced myocardial hypertrophy in mice does not require gp91phox Circulation 109 2004 1168 1171 (Pubitemid 38332622)
27. J.K. Bendall, A.C. Cave, C. Heymes, N. Gall, and A.M. Shah Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice Circulation 105 2002 293 296 (Pubitemid 34106175)
28. J.A. Byrne, D.J. Grieve, J.K. Bendall, J.M. Li, C. Gove, J.D. Lambeth, A.C. Cave, and A.M. Shah Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy Circ. Res. 93 2003 802 805
29. M. Zhang, A.C. Brewer, K. Schroder, C.X. Santos, D.J. Grieve, M. Wang, N. Anilkumar, B. Yu, X. Dong, S.J. Walker, R.P. Brandes, and A.M. Shah NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis Proc. Natl. Acad. Sci. U. S. A. 107 2010 18121 18126
30. D. Lloyd-Jones, R.J. Adams, T.M. Brown, M. Carnethon, S. Dai, G. De Simone, T.B. Ferguson, E. Ford, K. Furie, C. Gillespie, A. Go, K. Greenlund, N. Haase, S. Hailpern, P.M. Ho, V. Howard, B. Kissela, S. Kittner, D. Lackland, L. Lisabeth, A. Marelli, M.M. McDermott, J. Meigs, D. Mozaffarian, M. Mussolino, G. Nichol, V.L. Roger, W. Rosamond, R. Sacco, P. Sorlie, T. Thom, S. Wasserthiel-Smoller, N.D. Wong, and J. Wylie-Rosett Heart disease and stroke statistics-2010 update: a report from the American Heart Association Circulation 121 2010 e46 e215
31. M.F. Hill, and P.K. Singal Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats Am. J. Pathol. 148 1996 291 300 (Pubitemid 26019664)
32. T. Ide, H. Tsutsui, S. Hayashidani, D. Kang, N. Suematsu, K. Nakamura, H. Utsumi, N. Hamasaki, and A. Takeshita Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction Circ. Res. 88 2001 529 535 (Pubitemid 32240917)
33. S. Kinugawa, H. Tsutsui, S. Hayashidani, T. Ide, N. Suematsu, S. Satoh, H. Utsumi, and A. Takeshita Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress Circ. Res. 87 2000 392 398
34. P.A. Krijnen, C. Meischl, C.E. Hack, C.J. Meijer, C.A. Visser, D. Roos, and H.W. Niessen Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction J. Clin. Pathol. 56 2003 194 199 (Pubitemid 36308034)
35. T. Fukui, M. Yoshiyama, A. Hanatani, T. Omura, J. Yoshikawa, and Y. Abe Expression of p22-phox and gp91-phox, essential components of NADPH oxidase, increases after myocardial infarction Biochem. Biophys. Res. Commun. 281 2001 1200 1206 (Pubitemid 32924546)
36. M.R. Hoffmeyer, S.P. Jones, C.R. Ross, B. Sharp, M.B. Grisham, F.S. Laroux, T.J. Stalker, R. Scalia, and D.J. Lefer Myocardial ischemia/reperfusion injury in NADPH oxidase-deficient mice Circ. Res. 87 2000 812 817
37. C. Doerries, K. Grote, D. Hilfiker-Kleiner, M. Luchtefeld, A. Schaefer, S.M. Holland, S. Sorrentino, C. Manes, B. Schieffer, H. Drexler, and U. Landmesser Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction Circ. Res. 100 2007 894 903 (Pubitemid 46555695)
38. Y.H. Looi, D.J. Grieve, A. Siva, S.J. Walker, N. Anilkumar, A.C. Cave, M. Marber, M.J. Monaghan, and A.M. Shah Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction Hypertension 51 2008 319 325 (Pubitemid 351159945)
39. K.J. Schimmel, D.J. Richel, R.B. van den Brink, and H.J. Guchelaar Cardiotoxicity of cytotoxic drugs Cancer Treat. Rev. 30 2004 181 191 (Pubitemid 38418056)
40. K. Sorensen, G. Levitt, C. Bull, J. Chessells, and I. Sullivan Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity J. Clin. Oncol. 15 1997 61 68 (Pubitemid 27020558)
41. S. Geiger, V. Lange, P. Suhl, V. Heinemann, and H.J. Stemmler Anticancer therapy induced cardiotoxicity: review of the literature Anticancer Drugs 21 2010 578 590
42. L.C. Kremer, H.J. van der Pal, M. Offringa, E.C. van Dalen, and P.A. Voute Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review Ann. Oncol. 13 2002 819 829 (Pubitemid 34752678)
43. L.M. Buja, V.J. Ferrans, R.J. Mayer, W.C. Roberts, and E.S. Henderson Cardiac ultrastructural changes induced by daunorubicin therapy Cancer 32 1973 771 788
44. P.K. Singal, B. MacLeod, and C.M. Deally Adriamycin-induced leakage of lysosomal enzymes in vitro Mol. Cell. Biochem. 81 1988 89 94
45. 2 +-ATPase gene transcription Circ. Res. 86 2000 8 14 (Pubitemid 30044162)
46. N. Gebbia, C. Flandina, G. Leto, F.M. Tumminello, R. Sanguedolce, V. Candiloro, M. Gagliano, and L. Rausa The role of histamine in doxorubicin and teniposide-induced cardiotoxicity in dog and mouse Tumori 73 1987 279 287 (Pubitemid 17110672)
47. H.M. Olson, D.M. Young, D.J. Prieur, A.F. LeRoy, and R.L. Reagan Electrolyte and morphologic alterations of myocardium in adriamycin-treated rabbits Am. J. Pathol. 77 1974 439 454
48. D. Bagchi, M. Bagchi, E.A. Hassoun, J. Kelly, and S.J. Stohs Adriamycin-induced hepatic and myocardial lipid peroxidation and DNA damage, and enhanced excretion of urinary lipid metabolites in rats Toxicology 95 1995 1 9
49. A. Hiona, A.S. Lee, J. Nagendran, X. Xie, A.J. Connolly, R.C. Robbins, and J.C. Wu Pretreatment with angiotensin-converting enzyme inhibitor improves doxorubicin-induced cardiomyopathy via preservation of mitochondrial function J. Thoracic Cardiovasc. Surg. 142 2010 396 403
50. B. Srdjenovic, V. Milic-Torres, N. Grujic, K. Stankov, A. Djordjevic, and V. Vasovic Antioxidant properties of fullerenol C60(OH)24 in rat kidneys, testes, and lungs treated with doxorubicin Toxicol. Mech. Methods 20 2010 298 305
51. A.L. Ferreira, L.S. Matsubara, and B.B. Matsubara Anthracycline-induced cardiotoxicity Cardiovasc. Hematol. Agents Med. Chem. 6 2008 278 281
52. O. Marcillat, Y. Zhang, and K.J. Davies Oxidative and non-oxidative mechanisms in the inactivation of cardiac mitochondrial electron transport chain components by doxorubicin Biochem. J. 259 1989 181 189 (Pubitemid 19100513)
53. S. Deng, A. Kruger, A.L. Kleschyov, L. Kalinowski, A. Daiber, and L. Wojnowski Gp91phox-containing NAD(P)H oxidase increases superoxide formation by doxorubicin and NADPH Free Radic. Biol. Med. 42 2007 466 473 (Pubitemid 46162116)
54. Y. Zhao, D. McLaughlin, E. Robinson, A.P. Harvey, M.B. Hookham, A.M. Shah, B.J. McDermott, and D.J. Grieve Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with doxorubicin chemotherapy Cancer Res. 70 2010 9287 9297
55. M. Gilleron, X. Marechal, D. Montaigne, J. Franczak, R. Neviere, and S. Lancel NADPH oxidases participate to doxorubicin-induced cardiac myocyte apoptosis Biochem. Biophys. Res. Commun. 388 2009 727 731
56. S. Heumuller, S. Wind, E. Barbosa-Sicard, H.H. Schmidt, R. Busse, K. Schroder, and R.P. Brandes Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant Hypertension 51 2008 211 217 (Pubitemid 351159930)
57. S. Wind, K. Beuerlein, T. Eucker, H. Muller, P. Scheurer, M.E. Armitage, H. Ho, H.H. Schmidt, and K. Wingler Comparative pharmacology of chemically distinct NADPH oxidase inhibitors Br. J. Pharmacol. 161 2010 885 898
58. A.M. Feldman, and D. McNamara Myocarditis N. Engl. J. Med. 343 2000 1388 1398
59. C. Badorff, G.H. Lee, B.J. Lamphear, M.E. Martone, K.P. Campbell, R.E. Rhoads, and K.U. Knowlton Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy Nat. Med. 5 1999 320 326 (Pubitemid 29124369)
60. G. Torre-Amione, S. Kapadia, J. Lee, J.B. Durand, R.D. Bies, J.B. Young, and D.L. Mann Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart Circulation 93 1996 704 711
61. G. Torre-Amione, S. Kapadia, C. Benedict, H. Oral, J.B. Young, and D.L. Mann Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD) J. Am. Coll. Cardiol. 27 1996 1201 1206 (Pubitemid 26117714)
62. S. Paul Ventricular remodeling Crit. Care Nurs. Clin. North Am. 15 2003 407 411 (Pubitemid 38609496)
63. T. Kubota, C.F. McTiernan, C.S. Frye, S.E. Slawson, B.H. Lemster, A.P. Koretsky, A.J. Demetris, and A.M. Feldman Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha Circ. Res. 81 1997 627 635 (Pubitemid 27432751)
64. M.A. Beck, R.S. Esworthy, Y.S. Ho, and F.F. Chu Glutathione peroxidase protects mice from viral-induced myocarditis FASEB J. 12 1998 1143 1149 (Pubitemid 28418944)
65. H. Shimazaki, K. Watanabe, P.T. Veeraveedu, M. Harima, R.A. Thandavarayan, W. Arozal, H. Tachikawa, M. Kodama, and Y. Aizawa The antioxidant edaravone attenuates ER-stress-mediated cardiac apoptosis and dysfunction in rats with autoimmune myocarditis Free. Radic. Res. 44 2010 1082 1090
66. V. Sukumaran, K. Watanabe, P.T. Veeraveedu, M. Ma, N. Gurusamy, V. Rajavel, K. Suzuki, K. Yamaguchi, M. Kodama, and Y. Aizawa Telmisartan ameliorates experimental autoimmune myocarditis associated with inhibition of inflammation and oxidative stress Eur. J. Pharmacol. 652 2011 126 135
67. K.T. Moe, N.O. Yin, T.M. Naylynn, K. Khairunnisa, M.A. Wutyi, Y. Gu, M.S. Atan, M.C. Wong, T.H. Koh, and P. Wong Nox2 and Nox4 mediate tumor necrosis factor-alpha-induced ventricular remodeling in mice J. Cell. Mol. Med. 2011
68. L. Cai, and Y.J. Kang Oxidative stress and diabetic cardiomyopathy: a brief review Cardiovasc. Toxicol. 1 2001 181 193 (Pubitemid 37013746)
69. F. Giacco, and M. Brownlee Oxidative stress and diabetic complications Circ. Res. 107 2010 1058 1070
70. R. Lorenzi, M.E. Andrades, R.C. Bortolin, R. Nagai, F. Dal-Pizzol, and J.C. Moreira Glycolaldehyde induces oxidative stress in the heart: a clue to diabetic cardiomyopathy? Cardiovasc. Toxicol. 10 2010 244 249
71. M. Olukman, C.E. Orhan, F.G. Celenk, and S. Ulker Apocynin restores endothelial dysfunction in streptozotocin diabetic rats through regulation of nitric oxide synthase and NADPH oxidase expressions J. Diabetes Complications 24 2010 415 423
72. N.D. Roe, D.P. Thomas, and J. Ren Inhibition of NADPH oxidase alleviates experimental diabetes-induced myocardial contractile dysfunction Diabetes Obes. Metab. 13 2011 465 473
73. S. Jesmin, S. Zaedi, N. Shimojo, M. Iemitsu, K. Masuzawa, N. Yamaguchi, C.N. Mowa, S. Maeda, Y. Hattori, and T. Miyauchi Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts Am. J. Physiol. Endocrinol. Metab. 292 2007 E1030 E1040
74. J. Klimas, J. Kmecova, S. Jankyova, D. Yaghi, E. Priesolova, Z. Kyselova, P. Musil, P. Ochodnicky, P. Krenek, J. Kyselovic, and S. Matyas Pycnogenol improves left ventricular function in streptozotocin-induced diabetic cardiomyopathy in rats Phytother. Res. 24 2010 969 974
75. J. Li, H. Zhu, E. Shen, L. Wan, J.M. Arnold, and T. Peng Deficiency of rac1 blocks NADPH oxidase activation, inhibits endoplasmic reticulum stress, and reduces myocardial remodeling in a mouse model of type 1 diabetes Diabetes 59 2010 2033 2042
76. S.S. Barbieri, V. Cavalca, S. Eligini, M. Brambilla, A. Caiani, E. Tremoli, and S. Colli Apocynin prevents cyclooxygenase 2 expression in human monocytes through NADPH oxidase and glutathione redox-dependent mechanisms Free Radic. Biol. Med. 37 2004 156 165 (Pubitemid 38760252)
77. T. Schluter, A.C. Steinbach, A. Steffen, R. Rettig, and O. Grisk Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition Cardiovasc. Res. 80 2008 271 279
78. R.J. Aitken, H.M. Fisher, N. Fulton, E. Gomez, W. Knox, B. Lewis, and S. Irvine Reactive oxygen species generation by human spermatozoa is induced by exogenous NADPH and inhibited by the flavoprotein inhibitors diphenylene iodonium and quinacrine Mol. Reprod. Dev. 47 1997 468 482 (Pubitemid 27273158)
79. B.V. O'Donnell, D.G. Tew, O.T. Jones, and P.J. England Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase Biochem. J. 290 Pt 1 1993 41 49 (Pubitemid 23081198)
80. S. Lange, J. Heger, G. Euler, M. Wartenberg, H.M. Piper, and H. Sauer Platelet-derived growth factor BB stimulates vasculogenesis of embryonic stem cell-derived endothelial cells by calcium-mediated generation of reactive oxygen species Cardiovasc. Res. 81 2009 159 168
81. D.J. Stuehr, O.A. Fasehun, N.S. Kwon, S.S. Gross, J.A. Gonzalez, R. Levi, and C.F. Nathan Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs FASEB J. 5 1991 98 103 (Pubitemid 21892842)
82. J.M. Dodd-o, G. Zheng, H.S. Silverman, E.G. Lakatta, and R.C. Ziegelstein Endothelium-independent relaxation of aortic rings by the nitric oxide synthase inhibitor diphenyleneiodonium Br. J. Pharmacol. 120 1997 857 864 (Pubitemid 27122726)
83. S.A. Sanders, R. Eisenthal, and R. Harrison NADH oxidase activity of human xanthine oxidoreductase-generation of superoxide anion Eur. J. Biochem. 245 1997 541 548 (Pubitemid 27223884)
84. D.G. Tew Inhibition of cytochrome P450 reductase by the diphenyliodonium cation: kinetic analysis and covalent modifications Biochemistry 32 1993 10209 10215 (Pubitemid 23312452)
85. A. Majander, M. Finel, and M. Wikstrom Diphenyleneiodonium inhibits reduction of iron-sulfur clusters in the mitochondrial NADH-ubiquinone oxidoreductase (complex I) J. Biol. Chem. 269 1994 21037 21042 (Pubitemid 24266472)
86. 2 + currents in type I cells isolated from the neonatal rat carotid body Neurosci. Lett. 172 1994 63 66
87. 2 + pump Br. J. Pharmacol. 158 2009 790 796
88. V. Diatchuk, O. Lotan, V. Koshkin, P. Wikstroem, and E. Pick Inhibition of NADPH oxidase activation by 4-(2-aminoethyl)-benzenesulfonyl fluoride and related compounds J. Biol. Chem. 272 1997 13292 13301 (Pubitemid 27216760)
89. N. Wijayanti, T. Kietzmann, and S. Immenschuh Heme oxygenase-1 gene activation by the NAD(P)H oxidase inhibitor 4-(2-aminoethyl) benzenesulfonyl fluoride via a protein kinase B, p38-dependent signaling pathway in monocytes J. Biol. Chem. 280 2005 21820 21829 (Pubitemid 40827832)
90. R. Gerhard, H. John, K. Aktories, and I. Just Thiol-modifying phenylarsine oxide inhibits guanine nucleotide binding of Rho but not of Rac GTPases Mol. Pharmacol. 63 2003 1349 1355 (Pubitemid 36627230)
91. H. ten Freyhaus, M. Huntgeburth, K. Wingler, J. Schnitker, A.T. Baumer, M. Vantler, M.M. Bekhite, M. Wartenberg, H. Sauer, and S. Rosenkranz Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation Cardiovasc. Res. 71 2006 331 341
92. C. Stielow, R.A. Catar, G. Muller, K. Wingler, P. Scheurer, H.H. Schmidt, and H. Morawietz Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells Biochem. Biophys. Res. Commun. 344 2006 200 205
93. P. Niethammer, C. Grabher, A.T. Look, and T.J. Mitchison A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish Nature 459 2009 996 999
94. S. Wind, K. Beuerlein, M.E. Armitage, A. Taye, A.H. Kumar, D. Janowitz, C. Neff, A.M. Shah, K. Wingler, and H.H. Schmidt Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1/2 is reversed by NADPH oxidase inhibition Hypertension 56 2010 490 497
95. Y. Liu, H. Huang, W. Xia, Y. Tang, M. Yuan, Q. Tang, and C. Huang Inhibition of NADPH oxidase up-regulates connexin 43 and ameliorates electrical remodeling in rabbits with heart failure Biomed. Pharmacother. 2010
96. P. Zhang, M. Hou, Y. Li, X. Xu, M. Barsoum, Y. Chen, and R.J. Bache NADPH oxidase contributes to coronary endothelial dysfunction in the failing heart Am. J. Physiol. Heart Circ. Physiol. 296 2009 H840 H846
97. R.S. Gupte, V. Vijay, B. Marks, R.J. Levine, H.N. Sabbah, M.S. Wolin, F.A. Recchia, and S.A. Gupte Upregulation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase activity increases oxidative stress in failing human heart J. Cardiac Fail. 13 2007 497 506 (Pubitemid 47176930)
98. E. Borchi, M. Parri, L. Papucci, M. Becatti, N. Nassi, P. Nassi, and C. Nediani Role of NADPH oxidase in H9c2 cardiac muscle cells exposed to simulated ischaemia-reperfusion J. Cell. Mol. Med. 13 2009 2724 2735
99. Y.L. Li, L. Gao, I.H. Zucker, and H.D. Schultz NADPH oxidase-derived superoxide anion mediates angiotensin II-enhanced carotid body chemoreceptor sensitivity in heart failure rabbits Cardiovasc. Res. 75 2007 546 554 (Pubitemid 47080964)
100. G. Stef, A. Csiszar, Z. Ziangmin, P. Ferdinandy, Z. Ungvari, and G. Veress Inhibition of NAD(P)H oxidase attenuates aggregation of platelets from high-risk cardiac patients with aspirin resistance Pharmacol. Rep. 59 2007 428 436 (Pubitemid 47554823)